Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johan Neyts

Showing results (51-60 of 587) with videos related to

Pageof 59
Sort By:
Journal of Hepatology|June 28, 2011
In vitro selection and characterization of HCV replicons resistant to multiple non-nucleoside polymerase inhibitorsLeen Delang, Inge Vliegen, Pieter Leyssen, et al.
Antiviral Research|October 29, 2011
Identification of a novel resistance mutation for benzimidazole inhibitors of the HCV RNA-dependent RNA polymeraseLeen Delang, Mathy Froeyen, Piet Herdewijn, et al.
Antiviral Research|June 3, 2008
A case for developing antiviral drugs against polioMarc S Collett, Johan Neyts, John F Modlin
Antiviral Research|March 21, 2013
Intra-host variation structure of classical swine fever virus NS5B in relation to antiviral therapyAndy Haegeman, Robert Vrancken, Johan Neyts, et al.
Antimicrobial Agents and Chemotherapy|June 29, 2011
Comparative study of the genetic barriers and pathways towards resistance of selective inhibitors of hepatitis C virus replicationLeen Delang, Inge Vliegen, Mathy Froeyen, et al.
Current Opinion in Virology|October 14, 2016
Norovirus genetic diversity and evolution: implications for antiviral therapyJoana Rocha-Pereira, Jana Van Dycke, Johan Neyts
JHEP Reports : Innovation in Hepatology|June 23, 2021
A novel therapeutic HBV vaccine candidate induces strong polyfunctional cytotoxic T cell responses in miceRobbert Boudewijns, Ji Ma, Johan Neyts, et al.
Journal of Hepatology|March 12, 2016
Update on hepatitis E virology: Implications for clinical practiceYannick Debing, Darius Moradpour, Johan Neyts, et al.
Antiviral Research|November 24, 2015
Assessment of the activity of directly acting antivirals and other products against different genotypes of hepatitis C virus prevalent in resource-poor countriesHayat Khan, Jan Paeshuyse, Sheeba Murad, et al.
Microorganisms|April 3, 2021
Repurposing Drugs for Mayaro Virus: Identification of EIDD-1931, Favipiravir and Suramin as Mayaro Virus InhibitorsLana Langendries, Rana Abdelnabi, Johan Neyts, et al.
Pageof 59

Showing results (51-60 of 587) with videos related to

Sort By:
Pageof 59
Journal of Hepatology|June 28, 2011
In vitro selection and characterization of HCV replicons resistant to multiple non-nucleoside polymerase inhibitorsLeen Delang, Inge Vliegen, Pieter Leyssen, et al.
Antiviral Research|October 29, 2011
Identification of a novel resistance mutation for benzimidazole inhibitors of the HCV RNA-dependent RNA polymeraseLeen Delang, Mathy Froeyen, Piet Herdewijn, et al.
Antiviral Research|June 3, 2008
A case for developing antiviral drugs against polioMarc S Collett, Johan Neyts, John F Modlin
Antiviral Research|March 21, 2013
Intra-host variation structure of classical swine fever virus NS5B in relation to antiviral therapyAndy Haegeman, Robert Vrancken, Johan Neyts, et al.
Antimicrobial Agents and Chemotherapy|June 29, 2011
Comparative study of the genetic barriers and pathways towards resistance of selective inhibitors of hepatitis C virus replicationLeen Delang, Inge Vliegen, Mathy Froeyen, et al.
Current Opinion in Virology|October 14, 2016
Norovirus genetic diversity and evolution: implications for antiviral therapyJoana Rocha-Pereira, Jana Van Dycke, Johan Neyts
JHEP Reports : Innovation in Hepatology|June 23, 2021
A novel therapeutic HBV vaccine candidate induces strong polyfunctional cytotoxic T cell responses in miceRobbert Boudewijns, Ji Ma, Johan Neyts, et al.
Journal of Hepatology|March 12, 2016
Update on hepatitis E virology: Implications for clinical practiceYannick Debing, Darius Moradpour, Johan Neyts, et al.
Antiviral Research|November 24, 2015
Assessment of the activity of directly acting antivirals and other products against different genotypes of hepatitis C virus prevalent in resource-poor countriesHayat Khan, Jan Paeshuyse, Sheeba Murad, et al.
Microorganisms|April 3, 2021
Repurposing Drugs for Mayaro Virus: Identification of EIDD-1931, Favipiravir and Suramin as Mayaro Virus InhibitorsLana Langendries, Rana Abdelnabi, Johan Neyts, et al.
Pageof 59